IP Library Granted Patent US 9,393,227
Granted Patent B2
US 9,393,227 · App. 13/147,751 · Granted Jul 19, 2016

Nanoscale platinum compounds and methods of use thereof

Inventors: Shiladitya Sengupta (Waltham, MA); Abhimanyu Paraskar (Belmont, MA); Shivani Soni (Montgomery, AL); Sudipta Basu (Cambridge, MA); Poulomi Sengupta (Belmont, MA)
Assignee: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
A61K31/382A61K47/16A61K47/24A61K47/48046A61K47/48053A61K47/48176A61K47/48215C08F22/06C08F222/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,393,227
App. No.
13/147,751
Granted
Jul 19, 2016
Kind
B2
Abstract

The invention is directed to biocompatible conjugated polymer nanoparticles including a copolymer backbone, a plurality of sidechains covalently linked to said backbone, and a plurality of platinum compounds dissociably linked to said backbone. The invention is also directed to dicarbonyl-lipid compounds wherein a platinum compound is dissociably linked to the dicarbonyl compound. The invention is also directed to methods of treating cancer or metastasis. The methods includes selecting a subject in need of treatment for cancer or metastasis and administering to the subject an effective amount of any of the nanoparticles, compounds, or compositions of the invention.

Claims (13)

1. A conjugate comprising:

a dicarbonyl molecule, wherein a platinum compound is dissociably linked to the dicarbonyl molecule; and

a lipid molecule, wherein the dicarbonyl molecule is covalently linked to the lipid molecule,

wherein the dicarbonyl molecule is R′OC(O)—R—C(O)—, wherein R is C 1 -C 6 alkylene,

wherein the alkylene can comprise one or more double or triple bonds and/or the backbone of the alkylene can be interrupted with one or more of O, S, S(O), SO 2 , NH, C(O); and R′ is H, alkyl, alkenyl, alkynyl, aryl, heteroaryl, acylcyl, heterocyclyl, each of which can be optionally substituted; and

wherein the platinum compound is dissociably linked to the dicarbonyl molecule by a monocarboxylato bond and a Pt<->O coordinate bond.

2. The conjugate of claim 1 , wherein the dicarbonyl molecule is succinic acid.

3. The conjugate of claim 1 , wherein the dicarbonyl molecule is covalently linked to the lipid molecule by a linker.

4. The conjugate of claim 1 , wherein said platinum compound is selected from Pt(II) compounds, Pt(IV) compounds, and any combinations thereof.

5. The conjugate of claim 4 , wherein said platinum compound is a Pt(II) compound selected from the group consisting of cisplatin, oxaliplatin, carboplatin, paraplatin, sartraplatin, and combinations thereof.

6. The conjugate of claim 1 , wherein the conjugate is:

7. The conjugate of claim 1 , wherein the conjugate is

8. A method of treating cancer or metastasis comprising: administering to a subject in need thereof an effective amount of a conjugate of claim 1 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 9, 2015
From: BRIGHAM AND WOMEN'S HOSPITAL
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 037072/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2011
From: SENGUPTA, SHILADITYA; SONI, SHIVANI; PARASKAR, ABHIMANYU; BASU, SUDIPTA; SENGUPTA, POULOMI
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 026732/0178 →
Continuity (3)
Provisional Application 61149725 · Feb 4, 2009
Provisional Application 61240007 · Sep 4, 2009
Related Publication 20120189571A1 · Jul 26, 2012